Both in Pharmaceuticals

Elicio Therapeutics vs Actinium Pharmaceuticals

Over the past year ELTX returned −80.3% and ATNM returned +11.1%; their daily moves had a correlation of 0.06.

ELTX −80.3% ATNM +11.1%Growth of $1, one year, split-adjusted
MetricELTXATNM
Price$1.94$1.60
Market cap$52.6M$50.3M
Today+16.17%+15.94%
1 month+3.7%+35.6%
6 months−83.6%+22.1%
Year to date−75.6%+17.6%
1 year−79.5%+6.0%
Revenue growth (YoY)——
Gross margin—100.0%
Net margin—79.7%
P/E (TTM)—4.4×
Price / sales—1.4×
Net cash$13.9M$36.5M
Dividend yield——
Volatility (60d)66.6%87.3%
Short % of float19.0%2.3%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).